Tian, G., Nie, J., Dai, L., Hu, W., Zhang, J., Wu, D., . . . Fang, J. Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China. Frontiers Media S.A.
Chicago Style (17th ed.) CitationTian, Guangming, et al. Real-world Analysis of the Efficacy and Safety of Lorlatinib in ALK-positive Non-small Cell Lung Cancer Patients in China. Frontiers Media S.A.
MLA (9th ed.) CitationTian, Guangming, et al. Real-world Analysis of the Efficacy and Safety of Lorlatinib in ALK-positive Non-small Cell Lung Cancer Patients in China. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.